The SURMOUNT-5 trial evaluated the efficacy and safety of tirzepatide compared to semaglutide in adults with obesity or...

A popular diabetes drug may come with an unexpected trade-off-sexual health concerns in men. Medications known as GLP-1...

What if your waistline-not your weight-holds the real clue to your blood pressure risk? A growing body of research is...

What if the secret to fighting inflammation isn't a single "superfood," but the way everyday ingredients work together? ...

A new study from Italian researchers challenges the reliability of Body Mass Index as a tool for assessing body weight...

A major Indian study, the DiaFib-Liver Study, has revealed a concerning link between Type 2 Diabetes and serious liver...

A new study published in the European Heart Journal suggests that even short bursts of vigorous physical activity can...

A new study published in Nature Medicine suggests that Prediabetes can be reversed without weight loss, challenging the...

USV Private Limited, a leading name in diabetes care, has announced the launch of USEMA, its semaglutide injection, for...

The SURMOUNT-1 trial evaluated Tirzepatide a dual GIP/GLP1 agonist, in individuals with overweight (BMI more than or...

Cipla Limited has announced the launch of Afrezza, the world's only available inhaled insulin for adults living with...

A recent study published in Diabetologia suggests that the timing of the first meal of the day may influence blood sugar...